Hengrui Pharma(SH:600276)2014-04-27 16:00Financial Performance - Net profit attributable to shareholders rose by 15.95% to CNY 390,349,714.73 for the first quarter[12] - Operating revenue grew by 16.17% to CNY 1,721,396,845.85 year-on-year[12] - Basic earnings per share increased by 15.95% to CNY 0.2870[12] - Net profit attributable to shareholders of the parent company reached CNY 390,349,714.73, up from CNY 336,650,954.62, reflecting a growth of 15.9% year-over-year[25] - Basic and diluted earnings per share for Q1 2014 were CNY 0.2870, compared to CNY 0.2475 in Q1 2013, indicating an increase of 15.9%[26] - Operating revenue for Q1 2014 was CNY 1,530,290,562.86, an increase of 16.2% compared to CNY 1,316,808,845.94 in the same period last year[12] - Net profit for Q1 2014 reached CNY 350,463,176.05, up 2.5% from CNY 341,044,809.64 in Q1 2013[28] - Total comprehensive income for Q1 2014 was CNY 350,463,176.05, compared to CNY 341,044,809.64 in the previous year[28] - The company reported a total profit of CNY 412,555,220.41 for Q1 2014, an increase from CNY 401,503,908.70 in the same period last year[12] Assets and Liabilities - Total assets increased by 6.42% to CNY 7,683,547,775.39 compared to the previous year[12] - Total assets as of March 31, 2014, amounted to CNY 6,948,088,434.11, up from CNY 6,489,887,124.66 at the beginning of the year, representing a growth of 7.1%[22] - Total liabilities increased to CNY 1,008,663,125.22 from CNY 900,924,991.82, marking an increase of 12.0%[22] - The company's total equity reached CNY 5,939,425,308.89, up from CNY 5,588,962,132.84, reflecting a growth of 6.3%[22] - The company's net assets attributable to shareholders increased by 6.14% to CNY 6,747,606,028.10[12] Cash Flow - Net cash flow from operating activities decreased by 13.71% to CNY 284,690,568.34 compared to the same period last year[12] - Operating cash flow for Q1 2014 was CNY 284,690,568.34, a decrease of 13.7% from CNY 329,925,371.39 in Q1 2013[30] - Cash and cash equivalents increased to CNY 2,152,816,478.58 from CNY 1,896,892,776.30, showing a rise of 13.5%[20] - Cash and cash equivalents at the end of Q1 2014 were CNY 2,368,080,006.88, an increase from CNY 1,598,338,186.76 at the end of Q1 2013[32] - The beginning cash and cash equivalents balance was ¥1,896.89 million, up from ¥1,191.76 million year-over-year[36] - The ending cash and cash equivalents balance reached ¥2,152.82 million, compared to ¥1,446.58 million in the same period last year[36] Operating Costs and Expenses - Operating costs for Q1 2014 were CNY 1,248,727,319.75, an increase of 15.9% from CNY 1,075,944,184.74 in the previous year[25] - Total operating expenses for Q1 2014 were CNY 1,116,083,226.77, compared to CNY 1,014,485,000.30 in Q1 2013, reflecting a rise of 10.0%[12] - The company reported an increase in financial expenses, with a net financial cost of CNY -7,711,700.97 in Q1 2014, compared to CNY -1,229,219.95 in Q1 2013[12] Shareholder Information - The total number of shareholders reached 18,523 at the end of the reporting period[12] Government Support - The company received government subsidies amounting to CNY 1,504,100.00 during the quarter[11] Other Financial Metrics - The weighted average return on equity decreased by 0.29 percentage points to 5.96%[12] - The company reported a profit before tax of CNY 473,375,455.61, compared to CNY 406,198,994.09 in the same period last year, indicating a growth of 16.5%[25] - Sales revenue from goods and services received in Q1 2014 was CNY 1,838,127,140.58, up from CNY 1,729,424,835.22 in Q1 2013[29] - Inventory levels remained stable at CNY 405,617,021.08, slightly down from CNY 405,976,353.83, indicating a decrease of 0.1%[21] - Investment activities resulted in a net cash outflow of CNY -85,774,165.10 in Q1 2014, compared to CNY -61,001,026.99 in Q1 2013[31]